What is Leerink Partnrs’ Forecast for AXSM FY2028 Earnings?
Leerink Partnrs lowered their FY2028 earnings per share estimates for Axsome Therapeutics in a research note issued on ...
Leerink Partnrs Weighs in on Atyr PHARMA FY2024 Earnings
Analysts at Leerink Partnrs issued their FY2024 earnings per share estimates for shares of Atyr PHARMA in a research report issued on Tuesday, February 18th. Leerink Partnrs analyst F. Khurshid ...
FDA says Ozempic shortage is over, chilling boom in off-brand versions
The FDA has now resolved the shortages of Novo Nordisk’s and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage list
Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...
Fierce Healthcare13h
FDA declares semaglutide shortage over, spelling end to compounded GLP-1 market
The Food and Drug Administration on Friday announced that semaglutide, the active ingredient in weight loss drugs Ozempic and ...
Acadia Healthcare to Participate in March Investor Conferences
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in three investor conferences in March.
UnitedHealth shares dive after report of US investigation into Medicare billing
UnitedHealth Group shares tumbled Friday on a report that the U.S. Department of Justice has started an investigation into ...
Behind the Scenes of CVS Health's Latest Options Trends
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
UNIVERSAL HEALTH SERVICES, INC. TO PRESENT AT MARCH HEALTHCARE CONFERENCES
Universal Health Services, Inc. (NYSE: UHS) announced today that Steve Filton, Executive Vice President, and Chief Financial Officer will present at the following conferences: ...